Aratana Therapeutics (Kansas City, KS) a clinical-stage animal health company focused on pain, cancer, inflammation, cachexia and frailty, closed a $15.5M Series B financing. Participants include Ewing Marion Kauffman Foundation, MPM Capital, Cultivian Ventures and Avalon Ventures.